AMR is Rising — Stewardship Demands Global Leadership

Swipe to discover more

• First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

  bioMérieux, a world leader in in vitro diagnostics, announces the publication of a multi-country health economic analysis assessing the impact of deploying fast identification and antimicrobial susceptibility testing (ID/AST) early in the care pathway for patients with bloodstream infections at high-risk of sepsis.

  Read the press release
  

• The Value of Preventing Acute Kidney Injury for Cardiovascular Patients

  This article summarizes the findings of our “The Value of Preventing Acute Kidney Injury” Dossier, including the current burden of AKI for hospitals, where current risk assessment practices fall short, and how VIDAS® NEPHROCHECK® [TIMP-2 · IGFBP-7] from bioMérieux is designed to fill in the gaps.

  Read the blog post
  

• Predicting Sepsis-Related Shock Earlier: How AI Could Transform Critical Care

  In the ICU, minutes count — particularly for patients with sepsis, where a sudden drop in blood pressure can signal a dangerous turn. If care teams can see that change coming, even by a couple of hours, they can prepare, personalize treatment, and potentially prevent a crisis. That’s where interpretable, clinically grounded AI can help — turning routine hospital data into early warning signs.

  Read the news